Robert Yoder
Corporate Officer/Principal bij TREVENA, INC.
Vermogen: 73 083 $ op 31-03-2024
Actieve functies van Robert Yoder
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TREVENA, INC. | Corporate Officer/Principal | 10-12-2018 | - |
| Sales & Marketing | 11-06-2018 | 10-12-2018 |
Loopbaan van Robert Yoder
Eerdere bekende functies van Robert Yoder
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| OREXIGEN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-03-2015 | 01-06-2018 |
Opleiding van Robert Yoder
| Emory University | Masters Business Admin |
| Dickinson College | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Corporate Officer/Principal | 1 |
| Sales & Marketing | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TREVENA, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
- Beurs
- Insiders
- Robert Yoder
- Ervaring
